Eledon Pharmaceuticals (ELDN) Profit After Tax Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 33.04% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.60% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -154.28% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.80% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.53% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -3.84% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 47.10% |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - | -53.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53.59% |
| Dec 31, 2025 | 43.70% |
| Sep 30, 2025 | -18.58% |
| Jun 30, 2025 | -6.65% |
| Mar 31, 2025 | 13.00% |
| Dec 31, 2024 | -71.75% |
| Sep 30, 2024 | 114.29% |
| Jun 30, 2024 | -82.53% |
| Mar 31, 2024 | -40.62% |
| Dec 31, 2023 | -72.11% |
| Sep 30, 2023 | -17.26% |
| Jun 30, 2023 | -194.07% |
| Mar 31, 2023 | -9.62% |
| Dec 31, 2022 | -141.52% |
| Sep 30, 2022 | -53.54% |
| Jun 30, 2022 | -31.22% |
| Mar 31, 2022 | -26.43% |
| Dec 31, 2021 | -24.40% |
| Sep 30, 2021 | -41.08% |
| Jun 30, 2021 | -32.30% |
| Mar 31, 2021 | -44.69% |
| Dec 31, 2020 | -40.91% |
| Sep 30, 2020 | -27.42% |
| Jun 30, 2020 | 27.05% |
| Mar 31, 2020 | -81.22% |
| Dec 31, 2019 | -3.51% |
| Sep 30, 2019 | -12.44% |
| Jun 30, 2019 | -59.85% |
| Mar 31, 2019 | 24.69% |
| Dec 31, 2018 | 25.40% |
| Sep 30, 2018 | 33.43% |
| Jun 30, 2018 | 29.12% |
| Mar 31, 2018 | 40.41% |
| Dec 31, 2017 | 30.21% |
| Sep 30, 2017 | 22.54% |
| Jun 30, 2017 | -4.42% |
| Mar 31, 2017 | 34.31% |
| Dec 31, 2016 | 12.22% |
| Sep 30, 2016 | 15.43% |